Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Enhabit, Inc ( (EHAB) ) is now available.
Enhabit, Inc. sold its investment interest in Medalogix, a healthcare predictive data and analytics company, for approximately $21 million following Medalogix’s merger with Forcura in a private equity-backed transaction on March 19, 2025. The proceeds from this sale are expected to be used by Enhabit, Inc. to reduce debt under its credit agreement, potentially impacting its financial stability and operations.
More about Enhabit, Inc
YTD Price Performance: 18.97%
Average Trading Volume: 315,015
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $469M
Find detailed analytics on EHAB stock on TipRanks’ Stock Analysis page.